Study Stopped
COVID changed the nature in which this study had value.
Remote Mindfulness Education PLV
Remote Mindfulness-Education Intervention for Women With Provoked Localized Vulvodynia: A Randomized Clinical Study
Sponsor study identifier
interventional
46
1 country
1
Study Start
May 1, 2018
Actual (reported)Primary Completion
September 1, 2026
Actual (reported)Study Completion
September 30, 2026
Actual (reported)This is a study designed to learn more about the use of an online remote education and mindfulness practice program for the pain and anxiety associated with provoked localized vulvodynia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 30, 2026
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2018
Actual (reported)May 17, 2018
Actual (reported)May 30, 2018
Actual (reported)September 1, 2026
Actual (reported)September 30, 2026
Actual (reported)Change in Female Sexual Distress Scale (FSDS) at 8 weeks
The change in distress relating to sexual activity, measured by a change in the FSDS from baseline (study enrollment) survey. Participants will complete a Female Sexual Distress Scale (FSDS) survey to rate their feelings associated with sexual activities. Survey questions are on a number scale of 0 (Never) to 4 (Always). The FSDS surveys will be completed at baseline and 8 weeks after study enrollment.
Baseline & 8 weeks
Change in Tampon Test Pain Scores at 8 weeks
Baseline & 8 weeks
Mindfulness practice using guided HeadSpace medications plus educational materials
Educational materials only
Women in the mindfulness + education group will be asked to meditate daily, 10 minutes a day for the first 4 weeks with the option to increase their time to 20 minutes daily during the second 4 weeks. Women will also receive educational materials each week addressing different themes such as; "Introduction and Overview", "The Vulva", "Provoked Localized Vulvodynia (PLV)", "Treatment of PVL", "The Pelvic Floor", "Sexuality", "Chronic Pain", and "Promoting Sexual Health".
Oregon Health & Science University
Portland, Oregon, 97238, United States
Catherine Leclair, MD
Oregon Health and Science University
46 participants (actual enrollment reported by the registry).
First Submitted
May 17, 2018
First Posted
May 30, 2018
Study Start
May 1, 2018
Actual (reported)Gestation Diabetes N'Teractive Media-based Education (GDnME)
Women will also receive educational materials each week addressing different themes such as; "Introduction and Overview", "The Vulva", "Provoked Localized Vulvodynia (PLV)", "Treatment of PVL", "The Pelvic Floor", "Sexuality", "Chronic Pain", and "Promoting Sexual Health".
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2026
Actual (reported)Study Completion
September 30, 2026
Actual (reported)Last Updated
October 26, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: